Expert Pitch

"We've got to get our act together" on public health measures to combat COVID, says Fauci

Sbarro Health Research Organization (SHRO)

Newswise — In his remarks upon accepting the Leonardo da Vinci Award for Leadership in Health and Science, presented by the National Italian American Foundation (NIAF), Dr. Fauci signals optimism that one of the vaccines currently being tested will be shown to be effective, adding a very important tool in the fight against the global COVID pandemic, while stating plainly the need for vigilance in public health measures. 

"There will be an end to this," says Fauci, "we're gonna get a vaccine and the vaccine is going to diminish the infection rate. That together with good public health measures," he assures, "we will get back gradually to some form of normality, little by little."

Fauci goes on to say that, "Many states are starting to rebound now and that's very dangerous as we go into the cooler months of the Fall...The threat and the risk of having a resurgance of cases is much, much greater."

"So, we've really got to get our act together and start  all across the board, uniformly, doing those public health measures of uniform wearing of masks, keep a physical distance, avoidNIA crowds," Fauci concludes.

NIAF board member and Sbarro Health Research Organization (SHRO) founder and president Dr. Antonio Giordano, M.D., Ph.D., congratulates Dr. Anthony Fauci on his award  at this year’s NIAF Anniversary Gala, held virtually on October 31st, 2020. 

“Dr. Fauci is being honored at this year’s gala in recognition of his profound contribution to the fight against this terrible, global pandemic,” Giordano says, “particularly in the face of so many unprecedented challenges. Dr. Fauci has been involved with NIAF since it’s founding, and he truly represents the excellence in scholarship and public service that the Italian-American community has proudly brought to this nation for many centuries,” Giordano concludes. 

NIAF also plans to honor Dr. Fauci with a scholarship in his name, to support the work of promising Italian and Italian-American researchers. 

"The NIAF is pleased to also award the Fauci Scholarships, a $100,000 grant to be divided equally between an American and Italian post-doctoral research fellow," says Joseph V. Del Raso, Chair Emeritus, Chair of NIAF Italia, and member of the Executive Management Committee. 

Dr. Giordano will lead a peer reviewed selection process for the award of the grants. 

"At SHRO, we have a proven record of successful collaborations among Italian and American scientists," Giordano says. "I am honored to lead this effort as we cultivate excellence among the next generations of scientists to follow Dr. Fauci's example."

NIAF and SHRO also acknowledge American and Italian scientists working the front lines of the pandemic, and those working to develop a vaccine and therapeutic treatments. 

"Now more than ever," Del Raso says, "NIAF is honored to serve as a bridge between Italian and American cooperation, especially in these scientific and humanitarian causes."

The NIAF, now in it’s 45th year, seeks to recognize Italian and Italian-American achievements in business, art, science, finance, music and medicine. Additional guests of this year’s virtual program include filmmaker Francis Ford Coppola, actors John Turturro and Isabella Rosellini, former Major League Baseball star Mike Piazza, and legendary vocalist Tony Bennett. 

About the Sbarro Health Research Organization
The Sbarro Health Research Organization (SHRO) is non-profit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. To learn more about the SHRO please visit www.shro.org



Filters close

Showing results

110 of 5833
Newswise: Biophysical Study Sheds Light on Potentially Druggable Process of SARS-CoV-2 Replication
Released: 16-Jun-2021 12:50 PM EDT
Biophysical Study Sheds Light on Potentially Druggable Process of SARS-CoV-2 Replication
National Institute of Biomedical Imaging and Bioengineering

This study investigates how the nucleocapsid protein, or N protein, of the SARS-CoV-2 virus packages the viral genome.

Newswise: ‘Wonder material’ can be used to detect COVID-19 quickly, accurately
Released: 16-Jun-2021 11:55 AM EDT
‘Wonder material’ can be used to detect COVID-19 quickly, accurately
University of Illinois at Chicago

Researchers at the University of Illinois Chicago have successfully used graphene — one of the strongest, thinnest known materials — to detect the SARS-CoV-2 virus in laboratory experiments.

Newswise: UCLA-led Research Finds Connections Between Air Quality and COVID Vulnerability
Released: 16-Jun-2021 11:05 AM EDT
UCLA-led Research Finds Connections Between Air Quality and COVID Vulnerability
UCLA Fielding School of Public Health

Even as governments across the United States consider lifting mask mandates and relaxing preventative measures as vaccination numbers creep up, new research from a UCLA-led team has found that such basic techniques significantly reduce the risk of getting COVID-19. In addition, the research found that U.S. counties with higher exposures to poor air quality, historically, saw higher county-level COVID-19 mortality rates in 2020.

Newswise: Story Tips from Johns Hopkins Experts on COVID-19
Released: 16-Jun-2021 11:00 AM EDT
Story Tips from Johns Hopkins Experts on COVID-19
Johns Hopkins Medicine

NEWS STORIES IN THIS ISSUE: - Stressed About “Returning to Normal”? Here Are Tips to Ease Into the Transition - Be Your Brother’s Keeper: Steps for Faith-Based Communities to Reopen Safely

Newswise: Virtual Event For June 17, 11AM EDT: COVID-19 Vaccines and Male Fertility
Released: 16-Jun-2021 8:55 AM EDT
Virtual Event For June 17, 11AM EDT: COVID-19 Vaccines and Male Fertility
Newswise

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

Released: 16-Jun-2021 8:00 AM EDT
Two COVID-19 Vaccines Show Safety, Strong Immunity in Infant Model
University of North Carolina School of Medicine

The Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research. There were no adverse effects.

access_time Embargo lifts in 2 days
Embargo will expire: 17-Jun-2021 5:00 AM EDT Released to reporters: 16-Jun-2021 5:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Jun-2021 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Data and Safety Review Board Reports How it Monitored the COVID-19 Vaccine Trials
Released: 15-Jun-2021 2:55 PM EDT
Data and Safety Review Board Reports How it Monitored the COVID-19 Vaccine Trials
University of Alabama at Birmingham

Evaluation of three vaccine candidates during the COVID-19 pandemic fell to 12 experts of the federally appointed COVID-19 Vaccine Data and Safety Monitoring Board. This team has now taken the unusual step of publishing details of their review process in The Journal of Infectious Diseases.

Released: 15-Jun-2021 1:55 PM EDT
NCCN Policy Summit Explores How COVID-19 Pandemic Can Lead to Improvements in Cancer Care
National Comprehensive Cancer Network® (NCCN®)

NCCN Policy Summit examines the impact of the past year on oncology policy in the U.S., such as resuming recommended screening and clinical trials, applying health innovations from the COVID-19 pandemic to cancer treatment, and addressing systemic inequalities that lead to disparities in outcomes.


Showing results

110 of 5833

close
2.74616